TotalMarketCap

Quantum Biopharma

QNTMNasdaq CanadaHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$17.783 M

$2.10 -4.98%

Close of 6 Nov 2026

As of 6 Nov 2026, Quantum Biopharma (QNTM) has a market capitalization of $17.8M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

—

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #387Quoin PharmaceuticalsQNRX$18.5M
  2. #388Actuate TherapeuticsACTU$18.4M
  3. #389Quantum BiopharmaQNTM$17.8M
  4. #390Akari TherapeuticsAKTX$17.5M
  5. #391Context TherapeuticsCNTX$17.2M

What if Quantum Biopharma were worth as much as…

Open the what-if tool →

Gold $28.2T

$3,334,457

Per share 1,587,837× higher

Bitcoin $1.53T

$180,421.67

Per share 85,915× higher

Apple $5.02T

$592,307.50

Per share 282,051× higher

Or at a round number

$50.0M$100.0M$200.0M$500.0M

Where these numbers come from

Share counts and financials for Quantum Biopharma are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.